Effectiveness and Safety of OnabotulinumtoxinA in Adolescent Patients with Chronic Migraine

Chronic migraine (CM) significantly affects underage individuals. The study objectives are (1) to analyze the effectiveness and safety of onabotulinumtoxinA (BTX-A) in adolescents with CM; (2) to review the literature on BTX-A use in the pediatric population. This prospective observational study inc...

書誌詳細
出版年:	Toxins
主要な著者:	Laura Gómez-Dabó, Edoardo Caronna, Rut Mas-de-les-Valls, Víctor J. Gallardo, Alicia Alpuente, Marta Torres-Ferrus, Patricia Pozo-Rosich
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2024-05-01
主題:	migraine onabotulinumtoxinA adolescents teenagers children
オンライン･アクセス:	https://www.mdpi.com/2072-6651/16/5/221

類似資料

OnabotulinumtoxinA: Still the Present for Chronic Migraine
著者:: Carlo Baraldi, 等
出版事項: (2023-01-01)

Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
著者:: María Pilar Navarro-Pérez, 等
出版事項: (2024-06-01)

Pericranial Muscle Stiffness, Pain Thresholds, and Tenderness during a Treatment Cycle of OnabotulinumtoxinA for Chronic Migraine Prevention
著者:: Sebastian Worsaae Dalby, 等
出版事項: (2024-02-01)

Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study
著者:: Aubrey Manack Adams, 等
出版事項: (2023-08-01)

Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
著者:: Marta Torres-Ferrus, 等
出版事項: (2020-07-01)

Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
著者:: Larry Charleston, 等
出版事項: (2023-08-01)

Sequential use of OnabotulinumtoxinA and Erenumab in Chronic Migraine: Retrospective Real-World Report on Bidirectional Switching
著者:: Carolin Luisa Hoehne, 等
出版事項: (2025-08-01)

Beyond Pain: The Effects of OnabotulinumtoxinA Therapy on Sensitization and Interictal Symptoms in Chronic Migraine
著者:: Paolo Alonge, 等
出版事項: (2024-04-01)

Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway
著者:: Amanda Hansson-Hedblom, 等
出版事項: (2020-08-01)

Iron Deposits in Periaqueductal Gray Matter Are Associated with Poor Response to OnabotulinumtoxinA in Chronic Migraine
著者:: Clara Domínguez Vivero, 等
出版事項: (2020-07-01)

Assessing the Significance of the Circadian Time of Administration on the Effectiveness and Tolerability of OnabotulinumtoxinA for Chronic Migraine Prophylaxis
著者:: Emmanouil V. Dermitzakis, 等
出版事項: (2022-04-01)

OnabotulinumtoxinA Is an Effective Treatment for Reducing the Interictal Burden in Patients with Chronic Migraine: A Prospective Observational Study
著者:: Alejandro Sánchez-Huertas, 等
出版事項: (2025-09-01)

Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine
著者:: Andreas A. Argyriou, 等
出版事項: (2024-02-01)

Quantitative and Qualitative Pain Evaluation in Response to OnabotulinumtoxinA for Chronic Migraine: An Observational Real-Life Study
著者:: Claudia Altamura, 等
出版事項: (2023-04-01)

Patient Satisfaction with Aesthetic Outcomes Following OnabotulinumtoxinA Treatment for Chronic Migraine: A Cross-Sectional Study
著者:: Magdalena Boczarska-Jedynak, 等
出版事項: (2025-06-01)

Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review
著者:: Andrew M. Blumenfeld, 等
出版事項: (2024-09-01)

The effectiveness and predictors influencing the outcome of onabotulinumtoxinA treatment in chronic migraine: understanding from diverse patient profiles in a single session
著者:: Elif Ilgaz Aydinlar, 等
出版事項: (2024-06-01)

OnabotulinumtoxinA Modulates Visual Cortical Excitability in Chronic Migraine: Effects of 12-Week Treatment
著者:: Angelo Torrente, 等
出版事項: (2022-12-01)

Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
著者:: Dilara Onan, 等
出版事項: (2024-07-01)

Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study
著者:: Catherine Stark, 等
出版事項: (2019-07-01)

OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine
著者:: Andreas A. Argyriou, 等
出版事項: (2022-12-01)

OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity
著者:: Dilara Onan, 等
出版事項: (2022-12-01)

Onabotulinumtoxina in the Prevention of Migraine in Pediatric Population: A Systematic Review
著者:: Artemis Mavridi, 等
出版事項: (2024-06-01)

Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine
著者:: Damiana Scuteri, 等
出版事項: (2022-08-01)

Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection in Patients with Detrusor Hyperactivity and Impaired Contractility
著者:: Chung-Cheng Wang, 等
出版事項: (2016-03-01)

Real-World Insights into the Effectiveness and Tolerability of OnabotulinumtoxinA in Chronic Migraine: A Long-Term Evaluation of up to 11 Years
著者:: Antonio Santoro, 等
出版事項: (2025-04-01)

Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study
著者:: Fayyaz Ahmed, 等
出版事項: (2025-05-01)

Prospective Comparison of Longer Needle Lengths to Assess the Risk of OnabotulinumtoxinA-Associated Neck Pain in Patients with Chronic Migraine
著者:: Emmanouil V. Dermitzakis, 等
出版事項: (2022-06-01)

Evidencia y experiencia del uso de onabotulinumtoxinA en neuralgia del trigémino y cefaleas primarias distintas de la migraña crónica
著者:: S. Santos-Lasaosa, 等
出版事項: (2020-10-01)

Urinary tract infections in the intradetrusor onabotulinumtoxinA population
著者:: Esme White, 等
出版事項: (2023-04-01)

A Single-Group Study on the Effect of OnabotulinumtoxinA in Patients with Chronic Migraine Associated with Medication Overuse Headache: Pain Catastrophizing Plays a Role
著者:: Licia Grazzi, 等
出版事項: (2023-01-01)

Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice
著者:: Kwang Jin Ko, 等
出版事項: (2023-05-01)

Intradetrusor OnabotulinumtoxinA outcomes for overactive bladder in older adults
著者:: Rachel Stading, 等
出版事項: (2024-12-01)

Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
著者:: S. Santos-Lasaosa, 等
出版事項: (2020-10-01)

The Effect of OnabotulinumtoxinA on Headache Intensity and Number of Monthly Headache Days in Individuals with Chronic Migraine with Different Levels of Neck Disability
著者:: Dilara Onan, 等
出版事項: (2023-12-01)

Effects of a Single Session of OnabotulinumtoxinA Therapy on Sleep Quality and Psychological Measures: Preliminary Findings in a Population of Chronic Migraineurs
著者:: Angelo Torrente, 等
出版事項: (2023-08-01)

Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study
著者:: Ilenia Corbelli, 等
出版事項: (2022-12-01)

A Feasibility Study to Evaluate Changes in Urinary Metabolites after OnabotulinumtoxinA Injection for Refractory Overactive Bladder
著者:: Laura M. Tellechea, 等
出版事項: (2022-09-01)

SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication
著者:: Grace Forde, 等
出版事項: (2024-09-01)

Exploring Emotional Distress, Psychological Traits and Attitudes in Patients with Chronic Migraine Undergoing OnabotulinumtoxinA Prophylaxis versus Withdrawal Treatment
著者:: Valeria Donisi, 等
出版事項: (2020-09-01)